Kova review

What it is

Kova is run by LifeTech Apps Inc, a Delaware corporation with offices in Sherman Oaks, California, which describes itself as a technology platform: it doesn't prescribe, compound or dispense medication itself. Clinical care comes from the Telegra provider network, and the clinicians it names include Dr. Laurie Mercier, MD, and nurse practitioners Kimberli Hastings, Theresa Vergara and Craig Sorkin. Medication is filled by compounding pharmacies in Telegra's network, which Kova lists as E-RxHub, Absolute Pharmacy, Southend Pharmacy, Strive Pharmacy and Pharmacy Boudreaux's. The program centers on the Kova companion app, which handles medication reminders, injection-site rotation, protein and symptom tracking, and GLP-1 education. It's for adults 18 and older, says it serves all 50 states, and doesn't require insurance. General questions go to its support email, while anything about medication or refills goes through the patient portal.

How it works

You start with a short medical questionnaire covering your goals, history and whether you prefer an injectable or oral option. A licensed clinician reviews it online and decides whether a GLP-1 is appropriate; not everyone qualifies, and you aren't charged unless you're prescribed. If you are, the medication ships to your door and you get access to the companion app. From there, you can message your provider through the patient portal, request refills, track delivery and manage billing, and the medical provider offers support around the clock. Your clinician can adjust the dose as you go, using the history you log in the app. If you're switching from another GLP-1, list your current treatment so your provider can transition you safely. Labs aren't required to start, but if your provider orders them, you pay for them separately.

Pricing transparency

Kova publishes every plan. For compounded semaglutide, the one-month plan is $249 for the first month and then renews at $299 a month; the three-month plan is $179 a month ($537 upfront), six months is $149 a month ($894) and 12 months is $129 a month ($1,548). For tirzepatide, the one-month plan is $299 for the first month and then $399; longer plans are $249, $229 and $199 a month ($747, $1,374 and $2,388 upfront). Each plan includes clinician care, medication, delivery and the app, with no separate charge for the medication. You can pay upfront or monthly on longer plans. You can cancel any time, and access ends when your paid period runs out, but charges for a billing period that has already started aren't refunded. Its terms add that if you cancel a multi-month plan early, the months already shipped may be repriced at an early-cancellation rate, so a long plan is a real commitment. Insurance isn't used; ask your HSA or FSA plan about reimbursement.

Branded vs compounded

Kova offers compounded semaglutide and compounded tirzepatide, prepared by licensed 503A and 503B compounding pharmacies in the Telegra network. Its site states plainly that compounded GLP-1s are not FDA-approved and haven't been reviewed by the FDA for safety, effectiveness or quality, and that outcomes may differ from the brand-name trials it cites. The intake asks whether you prefer an injectable or oral option, but the site doesn't describe a specific oral product or price, so ask before you choose. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered. The site displays a LegitScript seal. A search of the FDA warning-letter database under the brand, its operating company and its web address returned no letters.

Pros and watch-outs

The evidence behind what Kova prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• GLP-1 medications and muscle: what the body-composition data actually show

  Some of the weight lost on GLP-1 drugs is lean mass (about 25% in the tirzepatide scan substudy), but fat falls faster, and resistance training plus protein is what protects muscle.

How Kova compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Shed

  A wide range of GLP-1 formats (injection, drops, lozenges, microdose)

  See Shed →
• Live Vital

  Pairing a GLP-1 with a wider peptide and longevity protocol

  See Live Vital →
• Henry Meds

  Simple flat-fee compounded access without insurance

  See Henry Meds →

More GLP-1 telehealth reviews: Remedy Meds · OrderlyMeds · Trinity Meds · MEDVi · Red Mountain Weight Loss · Allara Health